"At Dundee Dermatology near Chicago, we offer a multitude of skin care treatments for women and men looking to improve the health of their skin. Not only can we treat a variety of skin conditions, we also offer rejuvenation procedures to help you look and feel your best."

During the past decade, Dundee Dermatology conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 15 clinical trials were completed, i.e. on average, 88.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dundee Dermatology" #1 sponsor was "Pfizer" with 11 trials, followed by "Amgen" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dundee Dermatology" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Basilea Pharmaceutica" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Dundee Dermatology" are "Psoriasis" (9 trials), "Atopic Dermatitis" (7 trials), "Dermatitis, Atopic" (3 trials), "Eczema" (2 trials) and "Plaque Psoriasis" (2 trials). Many other conditions were trialed in "Dundee Dermatology" in a lesser frequency.

Most popular intervention types in "Dundee Dermatology" are "Drug" (21 trials), "Other" (5 trials), "Biological" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Lebrikizumab" (3 trials), "Abrocitinib 200 mg" (2 trials), "Apremilast" (2 trials) and "BMS-986165" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dundee Dermatology" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Dundee Dermatology". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Dundee Dermatology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Dundee Dermatology, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".